This week, Dr. Jordan Young from the late Dr. Murtaugh‘s lab shares his latest research project regarding the immune response against PRRS.
Key point
- PRRSV antibodies were determined to be broadly binding, but only homologously neutralizing, suggesting a polyclonal response, involving multiple PRRSV specific antibodies might be necessary for PRRSV neutralization.
- This means that vaccinations aiming to protect from infection likely need to involve exposure to multiple strains of PRRSV to induce a broad protective immunity, rather than relying on single-strain vaccines.